Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain

NCT03639415 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER_GOV

Sponsor class

Stopped There is no fund to support

Conditions

Cancer Pains

Interventions

DRUG: Increasing the Controlled-Release Oxycodone dose frequency

Sponsor

Fujian Cancer Hospital